Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Wolfgang, Ballensiefen"'
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-4 (2020)
Abstract This commentary presents the vision of the International Consortium for Personalised Medicine (ICPerMed) on how personalised medicine (PM) will lead to the next generation of healthcare by 2030. This vision focuses on five perspectives: indi
Externí odkaz:
https://doaj.org/article/a078a54056654f17b0480118f196d700
Autor:
Marko J, Kallio, Viktoriia, Starokozhko, Eleonora, Agricola, Manja, Burggraf, Anne, Heß, Wolfgang, Ballensiefen, Wiebke, Löbker, Yoana, Nuevo, Anna M G, Pasmooij, Peter G M, Mol
Publikováno v:
Clinical Pharmacology and Therapeutics, 113(2), 349-359. Nature Publishing Group
Important discoveries by academic drug developers hold the promise of bringing innovative treatments that address unmet medical needs to the market. However, the drug development process has proved to be challenging and demanding for academic researc
Autor:
Viktoriia Starokozhko, Anne Heß, Wiebke Löbker, Wolfgang Ballensiefen, Eleonora Agricola, Bettina Ziegele, Marko J. Kallio, Laurence O’Dwyer, Yoana Nuevo, Peter G. M. Mol, Anna M. G. Pasmooij
Publikováno v:
Nature Reviews Drug Discovery. 22:251-252
Autor:
Ilaria, Romagnuolo, Claudia, Mariut, Andrea, Mazzoni, Giovanni de, Santis, Ejner, Moltzen, Wolfgang, Ballensiefen, Carolin, Lange, Andrea, Frosini, Gianni, D'Errico
Publikováno v:
Personalized medicine. 18(5)
Autor:
Mauro Turrini, Wolfgang Ballensiefen, Gianni D'Errico, Christos Lionis, Christine Nardini, Elio Borgonovi, Venet Osmani, Thomas Neumuth, Paola Giulia Cormio, Andrea Frosini
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Personalized medicine
18 (2021): 283–294. doi:10.2217/pme-2020-0115
info:cnr-pdr/source/autori:Nardini, Christine; Osmani, Venet; Cormio, Paola G.; Frosini, Andrea; Turrini, Mauro; Lionis, Christos; Neumuth, Thomas; Ballensiefen, Wolfgang; Borgonovi, Elio; D'Errico, Gianni/titolo:The evolution of personalized healthcare and the pivotal role of European regions in its implementation/doi:10.2217%2Fpme-2020-0115/rivista:Personalized medicine (Print)/anno:2021/pagina_da:283/pagina_a:294/intervallo_pagine:283–294/volume:18
instname
Personalized medicine
18 (2021): 283–294. doi:10.2217/pme-2020-0115
info:cnr-pdr/source/autori:Nardini, Christine; Osmani, Venet; Cormio, Paola G.; Frosini, Andrea; Turrini, Mauro; Lionis, Christos; Neumuth, Thomas; Ballensiefen, Wolfgang; Borgonovi, Elio; D'Errico, Gianni/titolo:The evolution of personalized healthcare and the pivotal role of European regions in its implementation/doi:10.2217%2Fpme-2020-0115/rivista:Personalized medicine (Print)/anno:2021/pagina_da:283/pagina_a:294/intervallo_pagine:283–294/volume:18
Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare an
Autor:
Jeremy Pearson, David R. Wood, Robert Preissner, Wolfgang Ballensiefen, Francesco Cosentino, Frans Van de Werf, Axel R. Pries, Panos E. Vardas, Mathias Dunkel, Tomasz J. Guzik
Publikováno v:
Cardiovascular research. 116(5)
Publikováno v:
Impact. 2017:34-36
Autor:
Ralf Sudbrak, Wolfgang Ballensiefen, Erica Hackenitz, Angela Brand, Ulrike Bußhoff, Marleen Jansen, Denis Horgan, Lada Leyens, Jonathan A. Lal
Publikováno v:
Public Health Genomics, 17(5-6), 287-98. Karger
Public Health Genomics, 17, 287-298. S. Karger AG
Horgan, D, Jansen, M, Leyens, L, Lal, J A, Sudbrak, R, Hackenitz, E, Bußhoff, U, Ballensiefen, W & Brand, A 2014, ' An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe ', Public Health Genomics, vol. 17, pp. 287-298 . https://doi.org/10.1159/000368034
Public Health Genomics, 17, 287-298. S. Karger AG
Horgan, D, Jansen, M, Leyens, L, Lal, J A, Sudbrak, R, Hackenitz, E, Bußhoff, U, Ballensiefen, W & Brand, A 2014, ' An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe ', Public Health Genomics, vol. 17, pp. 287-298 . https://doi.org/10.1159/000368034
Background: Personalised medicine (PM) is an innovative way to produce better patient outcomes by using an individualised or stratified approach to disease and treatment rather than a collective treatment approach for patients. Despite its tangible a
Autor:
Surakameth Mahasirimongkol, Ron H.N. van Schaik, George P. Patrinos, Wolfgang Ballensiefen, Erica Hackenitz, Nicholas Inverso, Kimberly Fairley, Wasun Chantratita, Takis Vidalis, Alessio Squassina, Druckerei Stückle, Denis Horgan, Evangelia-Eirini Tsermpini, Angeliki Komianou, Marc S. Williams, Usa Chaikledkaew, Giannis Tzimas, James M Pitcavage, Eirini Mavroidi, Cristiana Pavlidis, Yuan Mai, Robert E. Smith, Konstantinos Poulas, Theodora Katsila, Ming Ta Michael Lee, Susan R. Snyder, Marleen Jansen, Elisavet Daki, Lada Leyens, Eleni Dalabira, Christina Mitropoulou, Athanassios Vozikis, Claudia Pisanu, Daniel D. Maeng, Jonathan A. Lal, Ralf Sudbrak, Wimon Suwankesawong, Ulrike Bußhoff, Satz Mengensatzproduktion, Jonathan A. Bock, Effy Vayena, Angela Brand, Marina Bartsakoulia, Yanfei Zhang, Emmanouil Viennas, Sotiria Kechagia
Publikováno v:
Public Health Genomics. 17:I-IV
Publikováno v:
Public Health Genomics, 18(5), 249-259. Karger
Scientific knowledge and our understanding of the human body and diseases have limited any possible treatment tailoring to each patient. The technological advances enabling the integration of various data sets (e.g. ‘-omics', microbiome, epigenetic